Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Estradiol Patch Medicaid Coverage by State Tier (2026 Guide)

By
Published Updated Last reviewed
5 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Drug / Estradiol transdermal patch, a prescription estrogen [1]
  • Brands / Climara once weekly; Vivelle-Dot twice weekly; Minivelle [1][3]
  • Generics / Generic estradiol transdermal patches are sold [1]
  • Supply, FDA update 2026-09-03 / Patches remain available; supply nearly doubled in a year; brands vary by pharmacy [2]
  • Compounded estradiol / Not FDA-approved; for use only when an FDA-approved drug cannot meet the need [4]

What is documented about patch access in 2026

On 2026-09-03 the FDA said it was aware of patients having trouble readily accessing their usual estradiol patches because of increased demand and that it is working with all six manufacturers [2]. Availability of certain products or brands may vary by pharmacy or location, the agency said, but estradiol patches remain available, and supply of FDA-approved patches has nearly doubled over the past year [2].

The FDA said demand rose following its November 2025 request that manufacturers revise menopausal hormone therapy labeling [5][2]. The update also says a pharmacist can check availability and may help locate another available FDA-approved estradiol patch [2].

Brand and generic patches: what the labels specify

Estradiol is sold as prescription Climara, Vivelle-Dot, Minivelle, and generic transdermal patches [1]. The Climara label specifies a starting dose of 0.025 mg per day, once-weekly application to the lower abdomen below the navel or the upper buttock, and no application to the breasts [1]. The Vivelle-Dot label specifies a starting dose of 0.0375 mg per day applied twice weekly to the lower abdomen or buttocks, and not to the breasts [3].

Compounded estradiol is not an approved patch

Compounded drugs are not FDA-approved, and the FDA says it does not verify their safety, effectiveness or quality before they are marketed. The agency says compounded drugs should only be used when a patient's needs cannot be met by an FDA-approved drug [4]. FDA-approved estradiol tablets and patches exist [4].

Frequently asked questions

Is there a generic estradiol patch?
Yes. Estradiol is sold as prescription Climara, Vivelle-Dot, Minivelle, and generic transdermal patches [1].
How often is each estradiol patch applied?
The Climara label specifies once-weekly application, starting at 0.025 mg per day [1]. The Vivelle-Dot label specifies twice-weekly application, starting at 0.0375 mg per day [3].
Why can I not always get my usual brand of patch?
The FDA said on 2026-09-03 that increased demand has made some products or brands harder to find at particular pharmacies, that patches remain available, and that supply of FDA-approved patches has nearly doubled over the past year. The update says a pharmacist can check availability and may help locate another available FDA-approved patch [2].
Is compounded estradiol FDA-approved?
No. Compounded drugs are not FDA-approved, and the FDA says it does not verify their safety, effectiveness or quality before they are marketed. The agency says compounded drugs should only be used when a patient's needs cannot be met by an FDA-approved drug, and FDA-approved estradiol tablets and patches exist [4].

References

  1. U.S. National Library of Medicine, DailyMed. Climara estradiol transdermal system (Bayer) prescribing information. Climara estradiol transdermal system (Bayer) label
  2. FDA Update on Estradiol Transdermal Patch Availability | FDA. FDA Update on Estradiol Transdermal Patch Availability | FDA
  3. U.S. National Library of Medicine, DailyMed. Vivelle-Dot estradiol transdermal system (Sandoz) prescribing information. Vivelle-Dot estradiol transdermal system (Sandoz) label
  4. Compounding and the FDA: Questions and Answers | FDA. Compounding and the FDA: Questions and Answers | FDA
  5. U.S. Food and Drug Administration. U.S. Food and Drug Administration
Evidence overview for Estradiol Patch Medicaid Coverage by State Tier (2026 Guide)